Shuttle Pharmaceuticals Holdings (SHPH) Income towards Parent Company (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Income towards Parent Company history runs 6 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

• In Q1 2026, Income towards Parent Company rose 24.62% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$11.2 million (down 31.4% YoY), while the FY2025 annual figure was -$11.9 million, down 55.54% from the prior year.
• Income towards Parent Company was -$2.2 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from -$2.8 million in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of -$524017.0 in Q2 2022 to a low of -$3.9 million in Q2 2025.
• Historically, Income towards Parent Company has averaged -$1.9 million across 5 years, with a median of -$1.9 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Income towards Parent Company slumped 492.21% in 2022, then surged 64.21% in 2024.
• A 5-year view of Income towards Parent Company shows it stood at -$2.7 million in 2022, then jumped by 39.65% to -$1.6 million in 2023, then soared by 64.21% to -$587079.0 in 2024, then tumbled by 368.86% to -$2.8 million in 2025, then advanced by 19.03% to -$2.2 million in 2026.
• The last three Income towards Parent Company figures came in at -$2.2 million (Q1 2026), -$2.8 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.